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Objective: To assess the potential benefit of the addition of a covered stent to a subintimal recanalized artery in patients
with femoro-popliteal occlusions.
Methods: From September 2003 to October 2005, we retrospectively analyzed all patients admitted for severe claudication
or critical limb ischemia related to long femoro-popliteal occlusions and treated with subintimal recanalization. Patients
were divided into two groups depending on whether they received a stent or not. All patients in the group treated with
stent received a stent graft, and the entire length of the recanalized artery was covered in each case. Demographic data,
indications, procedure, and outcomes were examined using survival analysis statistical techniques.
Results: Fifty-three patients (54 limbs) were treated consecutively for severe claudication (n 19) or critical limb ischemia
(n  34). Thirty-four (64%) had a stent placed, while 19 (35.8%) did not. The mean length of the lesions treated was
20.11 cm (range, 5-35 cm). Statistically, there was no significant difference in lesion length, Rutherford stage of
peripheral-artery disease, Transatlantic Inter-Society Consensus classification, and distal run-off between the two groups.
The technical success rate was 94.5%, and two out of the three failures were treated with surgical bypass in one case and
major amputation in the other. The third patient received only medical treatment. Combined procedures were required
in the treatment of 68.2% of limbs in the no-stent group and 55.8% in the stent group. Mean follow up was 16.9 months
(range, 1-35 months). At 1 year, primary, primary-assisted, and secondary patency for the stent vs no-stent groups was,
respectively, 61.8% vs 78.9% (P .49), 70.6% vs 78.9% (P .78), and 88.2% vs 78.9% (P .22). The 1-year limb salvage
rate for the stent vs no-stent group was 94.1% vs 100% (P  .7).
Conclusion: Combining subintimal angioplasty with a stent graft in femoro-popliteal lesions does not improve patency.
The limb salvage rate remains high after addition of a stent graft. Rigorous monitoring is recommended to diagnose and
treat restenosis early in order to improve patency. (J Vasc Surg 2010;52:1211-7.)Subintimal angioplasty (SA) was initially introduced to
treat long chronic occlusions of the superficial femoral
artery (SFA)1 and was then extended to the tibial arteries.2
Despite poor long-term patency,2-5 the procedure has
gained widespread acceptance owing to the good limb
salvage rate2,6 and the minimally-invasive aspect of the
procedure. The factors affecting patency after subintimal
angioplasty are not well defined. Many reports5,7,8 have
studied these factors but none of them advocate stenting.
Only three series9-11 report routine use of stents after SA.
The results are controversial and the benefit of the stent is
not clear.
This technique is based on the creation of a new lumen,
between the intima and the media, free from atheroma by
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doi:10.1016/j.jvs.2010.05.107using balloon angioplasty. In the procedure initially de-
scribed by Bolia et al,1 stents were used only in case of
suboptimal angioplasty, defined as residual stenosis 30%.
Our procedure differs from the initial procedure described
by Bolia in that we stented the entire length of the recana-
lized artery.
This study was designed to assess whether the addition
of a covered stent to a subintimal recanalized artery modi-
fies the results in terms of patency and limb salvage, com-
pared with the standard Bolia technique12 in patients with
long femoro-popliteal occlusions.
METHODS AND MATERIALS
We retrospectively reviewed all patients admitted to our
department from September 2003 to October 2005 for
severe claudication or critical limb ischemia (CLI) with
long femoro-popliteal occlusions (n  346) and treated
with subintimal angioplasty (n  53). During the same
period, 174 patients underwent above or below-knee fem-
oropopliteal bypass, eight patients with critical limb isch-
emia had primary amputation because of severe mental
impairment (clinical dementia) and/or function impair-
ment (elderly and non ambulatory patients), and 11 pa-
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alone with improvement of walking distance.
Patients were divided into two groups depending on
whether they were treated only with SA (group 1) or with
SA plus stenting (group 2). This cohort of patients repre-
sented 19.6% of the total number of patients treated during
the same period in our unit for lower limb ischemia and
11% of those treated for claudication. During the study
period, all patients with critical limb ischemia or disabling
claudication were evaluated by clinical examination and
duplex ultrasonography. They subsequently underwent ei-
ther magnetic resonance angiography (MRA) or digital
subtraction angiography (DSA) to assess the location and
extent of the atherosclerotic disease. SA was limited to
younger patients (active patients less than 50 years of age)
with disabling claudication (less than 100 meters) and to
either other patients with significant medical comorbidities or
cases of autologous veins that were unavailable for bypass.
The comorbid conditions included: recent myocardial in-
farction (6 weeks), symptomatic coronary disease, renal
insufficiency (creatinine level  2 mg/dL or dialysis-de-
pendant), or severe chronic obstructive pulmonary dis-
ease.13
The decision to undertake stenting or not depended on
the surgeon’s preference, the extent of the femoro-popliteal
occlusion above or below the knee, and the hemodynamic
results on the perioperative angiogram. For practical pur-
poses, stent graft was performed for all above-the-knee
femoro-popliteal occlusions for some surgeons and, for the
others, only in cases of blood flow limitation with dissection
flaps or residual stenosis greater than 30% after above-the-
knee femoro-popliteal recanalization. In no case stent graft
was used for below-the-knee occlusions. Combined proce-
dures included all endovascular or surgical procedures uti-
lized during the femoro-popliteal recanalization in order to
improve inflow and/or outflow.
In patients with critical limb ischemia and severe steno-
sis or occlusion above and/or below the femoro-popliteal
occlusion, we systematically performed the treatment of
these lesions in conjunction with the femoro-popliteal re-
canalization. For claudicants, we corrected only the iliac or
common femoral or profunda femoris artery stenosis as in
inflow procedure. Infrapopliteal artery lesions were not
treated in this group of patients.
The demographic data, associated comorbidities, indi-
cations, and occlusive lesions in each group are summarized
in Table I. According to the extent of the occlusion into the
femoro-popliteal segment and the site of reentry, we arbi-
trarily divided the lesion level into: (1) proximal, middle, or
distal SFA, (2) total SFA occlusion, (3) femoro-popliteal,
or (4) popliteal occlusion (Table II).
All procedures were performed in an operating room
under general anesthesia or local anesthesia with deep
sedation. The ipsilateral common femoral artery was the
preferred angiographic access. The controlateral femoral
artery puncture was used in case of flush SFA occlusion. For
patients with significant stenosis of common femoral artery
or the profunda femoris artery, a surgical approach with afemoral bifurcation endarterectomy was first performed;
thereafter, the patch graft used for the closure of the
arteriotomy was punctured, and the endovascular proce-
dure was achieved. An angiogram was made via a 5 Fr
sheath mainly to plan for the reentry zone. A 5 Fr straight
angiography catheter (Glidecath; Terumo Medical Corpo-
ration, Somerset, NJ) in combination with a soft angled
0.035 inch hydrophilic guide wire were commonly used to
perform the subintimal dissection. Sometimes, especially in
cases of very calcified artery or long occlusion, the progress
of the guide wire in the subintimal space was very difficult;
a 5 or 6 mm balloon catheter was used to dilate the
Table I. Demographic data
Group 1 (%)
(SA, n  19)
Group 2 (%)
(SA  stent,
n  34)
P
value
Age (years)
Mean 74.3 70.9 .22
Range 47-88 52-89
Male gender 11 (58) 24 (70) .34
Risk factors
Diabetes mellitus 11 (58) 15 (44) .33
History of smoking 8 (42) 21 (62) .16
Hypertension 15 (79) 23 (67) .38
Hyperlipidemia 6 (31) 14 (41) .48
Renal insuffisancy 6 (31) 7 (20) .28
ASA
II 4 (21) 9 (26)
III 12 (63) 21 (62) .86
IV 3 (15) 4 (12)
Previous lower extremity
bypass 1 (5) 6 (17) .20
Rutherford classification .07
III 3 (15) 16 (47)
IV 7 (37) 9 (26)
V and IV 9 (47) 9 (26)
Lesion length(cm)
Mean 15.7 21.3 .13
Range 5-35 6-30
TASC .24
B 0 4 (12)
C 8 (42) 8 (23)
D 11 (58) 20 (59)
Run-off vessels .11
1 or 0 leg artery 13 17
2 or 3 leg arteries 6 17
ASA, American Society of Anesthetists; SA, subintimal angioplasty; TASC,
Trans-Atlantic Inter-Society Consensus.
Table II. Levels of lesions
Group 1 (%)
(SA, n  19)
Group 2 (%)
(SA  stent, n  34)
Proximal, middle, or distal
SFA 5 14
Total SFA 0 5
Femoro-popliteal segment 9 15
Popliteal 5 0
SA, Subintimal angioplasty; SFA, superficial femoral artery.subintimal channel and help the advancement of the guide
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either with catheter guide wire manipulations or with sim-
ple pushing of the looped guide wire at the end of the
occlusion site. After confirmation of reentry, the whole
subintimal space was dilated with 6 mm x 80 mm balloon
angioplasty catheters (Wanda Balloon; SciMed, Boston
Scientific, Natick, Mass) for SFA lesions inflated at 12 to 14
atmospheres for 60 seconds, whereas 4 to 5 x 40 mm
balloon catheters (Wanda Balloon) were used for popliteal
angioplasty. An angiogram was then performed to assess
the results. When indicated, stents were deployed to cover
the entire length of the recanalized artery. Five or 6 mm
stent graft (Viabahn; W.L. Gore & Associates, Flagstaff,
Ariz) was exclusively used in these patients.
Technical success was defined as the creation of extralu-
minal dissection, reentry into the true lumen, and establish-
ment of antegrade flow through the new lumen with30%
residual stenosis. Following a successful procedure, the
patients in the non-stent group received aspirin and clopi-
dogrel for 1 month, and those in the stent group received
the same therapy for 6months, followed by either aspirin or
clopidogrel. All patients were monitored at 1, 6, and 12
months with a clinical examination and duplex scan. At
each office visit, all patients were checked through the
anti-platelet therapy they had, and practical guidelines were
communicated to the attending physician. More investiga-
tions with angiography or MRA were performed in cases of
worsened symptoms and/or recurrent stenosis of more
than 50% or thrombosis on duplex scan.
Continuous variables were expressed by mean and stan-
dard deviations, whereas categorical data were presented in
frequencies and percentages. Non-parametricMann-Whitney
tests were performed, when appropriate, to compare mean
scores across the groups, whereas 2 or Fisher exact tests
were used to compare frequencies.
Survival data were updated for March 2006 following
contact with the patients or their referring physicians. The
following variable was considered to be a potential prog-
nostic factor for survival: stent vs non-stent. Survival was
calculated only on technically successful SA, using the
Kaplan-Meier product limit method from the date of the
operation, and included the operative primary, primary-
assisted, and secondary patency, as well as related or unre-
lated death. Comparisons were made using the log-rank
test. P values of 0.05 or less were considered to be
statistically significant. This statistical analysis was per-
formed using the SPSS V13.0 software package (SPSS
Inc, Chicago, Ill).
RESULTS
A total of 53 patients (54 limbs) were consecutively
treated with SA for disabling claudication (n  19) or
critical limb ischemia (n  34) from September 2003 to
October 2005. Thirty-four limbs (64%) had a stent placed
(group 2), and 19 (35.8 %) did not (group 1). The two
groups were comparable with respect to age, the presence
of diabetes, American Society of Anesthetists (ASA) grade,
combined procedures, presentation (Rutherford classifica-tion14), and history of previous lower extremity bypass
(Table I). The mean length of the lesions treated was 20.11
cm (range, 5-35 cm); 15.8 cm in group 1 (range, 5-35 cm)
and 22.5 cm (range, 5-30 cm) in group 2. There was no
statistically significant difference in lesion length, Trans-
Atlantic Inter-Society Consensus (TASC) classification,
and the number of run-off vessels between the two groups.
The procedure was technically successful in 94.5% of
cases. In the three other cases, failure was attributed to the
inability to reenter the true lumen because of heavy calcifi-
cation (n  2) and the line suture from a previous bypass
(n  1). These patients underwent a surgical bypass in one
case, major amputation in another. The third patient with
disabling claudication received only medical treatment and
underwent no further medical intervention.
Combined procedures were required in the treatment of
59.2% (n  32) of limbs (68.2% in group 1 and 55.8% in
group 2) to improve inflow (n 23, 42.5%) or outflow (n
9, 16.6%). In CLI, these procedures were performed in 22
patients, including open femoral bifurcation endarterec-
tomy (n  13), iliac angioplasty with or without stenting
(n 4), and tibial artery angioplasty or recanalization (n
5). In claudicants, 10 patients had combined procedures
with open femoral bifurcation endarterectomy (n  6) or
iliac artery angioplasty with or without stenting (n  4) as
inflow procedures. There was no difference in the adjunc-
tive procedures between the two groups (P  .1). The
Viabahn stent graft was used in all cases. The mean diame-
ter of the stent graft used was 6 mm (range, 5-6 mm). The
mean number of stent grafts deployed in the recanalized
artery was 1.6 0.65 (range, 1-3) with a mean total length
of 21.25  10.26 cm.
There were two peri- or postprocedural complications
(5.8%) in group 2 (one groin hematoma and one groin
infection) and two (10.5%) in group 1 (one distal embolus
treated with thrombolysis and thromboaspiration and one
retroperitoneal hematoma). At 30 days, we had two deaths
in each group. All the patients concerned were 80 years
old, in ASA grade IV, with critical limb ischemia, and were
unfit for infrainguinal bypass. The two patients in group 1
died on days 5 and 6, respectively from congestive heart
failure and unexplained sudden death. In group 2, one
patient died of myocardial infarction on day 1 and the
second of general condition impairment owing to meta-
static cancer on day 7.
The mean follow up was 16.89 months (range, 1-35
months). At 1 year, the primary, primary-assisted, and
secondary patency rates were 78.9 % in group 1 and,
respectively, 61.8%, 70.6%, and 88.2% in group 2 (Figs
1-3). There was no significant difference in primary patency
(P  .49), in primary-assisted patency (P  .78), or in
secondary patency (P  .22) between the two groups.
Secondary intervention was performed in 70% of pa-
tients (n  7) in group 2 and 50% of patients (n  1) in
group 1 after occlusion of the treated arterial segment.
Three of the seven patients who had occluded the stents
Fig 1. Actuarial primary patency (Kaplan-Meier curves) of stent (group 2) vs no-stent group (group 1).
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Group 1 19 9 5 2
Group 2 34 17 11 6Fig 2. Actuarial primary-assisted patency (Kaplan-Meier curves) of stent (group 2) vs no-stent group (group 1).
Fig 3. Actuarial secondary patency (Kaplan-Meier curves) of stent (group 2) vs no-stent group (group 1).
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Secondary PatencyFig 4. Limb salvage rates (Kaplan-Meier curves) for all patients of stent (group 2) vs no-stent group (group 1).
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tient who occluded the treated artery had only mild clau-
dication.
The one-year limb salvage rate for the stent vs the
non-stent group was 94.1% vs 100% (P  .7; Fig 4). The
two cases of major (below-the-knee) amputation in the
stent group were in patients initially treated for CLI at 1
and 3months because of thrombosis in the first case and, in
the second case, infection and major tissue loss despite the
good permeability of the revascularization.
DISCUSSION
The standard treatment for long femoro-popliteal oc-
clusions remains bypass surgery. Since the subintimal an-
gioplasty technique was first developed in 1989,15 it has
become possible to treat long chronic occlusions of the SFA
as well as the tibial arteries. This technique offers some
advantages over infrainguinal bypass and conventional angio-
plasty and, for some investigators, is a real alternative.9,16
Since 2003, we have modified our policy regarding the man-
agement of occlusive disease with femoro-popliteal occlu-
sions. In order to avoid bypass and preserve the saphenous
veins in young patients with disabling claudication and suit-
able lesions for SA, in primary intention we attempt subin-
timal recanalization. The less invasive techniques using
intra- or extraluminal recanalization are also restricted to
patients with CLI and severe comorbidities or to those who
have unsuitable veins for bypass. The short-term safety and
feasibility of SA have been well established, with high
technical success rates (80%-90%) and a high rate of limb
salvage.2,6,17,18 Unfortunately, the patency rate remains
controversial, and, in recent studies, the primary patency
rates range between 22% and 74% at 12 months.2-5,19,20
In the initial technique described by Bolia,1 there was
no need to use a stent, except in cases of perforation or
intimal flaps at the entry site. In our establishment, we have
modified the Bolia technique12 with a view to improving
patency. We combine the standard SA technique with
stenting along the whole length of the recanalized artery in
order to contain the atherosclerotic plaque and intimal flap.
The stent is used only if the reentry site does not extend
beyond the knee joint, which avoids interference with later
bypass surgery in case of occlusion, and also reduces the risk
of stent fracture.
During the same period, we also treated long SFA
occlusions using the standard subintimal angioplasty tech-
nique. The choice between the two SA techniques, with or
without stenting, depended on the surgeon’s preference
and lesion extension in relation to the knee joint.
There is only one study9 that investigates the role of
stenting in improving the outcome of subintimal angio-
plasty by comparing two groups, with and without stent. In
this report, Schmieder et al9 showed that a selective stent
placed after SA resulted in similar patency to primary SA
without stents. Two other large studies10,11 assessed the
impact of routine stenting on patency after SA and reported
a relatively favorable outcome. Treiman et al,10 in a study of
29 patients, stented along the entire length of the dissection,found good short and intermediate-term patency, but poor
long-termpatency, probably explained bymyo-intimal hyper-
plasia. Kim et al11 combined primary stenting of the prox-
imal segment with SA for long occlusions, and obtained a
primary patency and limb salvage rate at 12 months of 52%
and 83%, respectively.
In our study, primary patency and primary-assisted
patency at 12 months in the stent group were, respectively,
61.8% and 70.6%. The two groups were totally comparable
with regard to the number of run-off vessels and occlusion
length. While the other studies used only self-expanding
nitinol stents,9-11 in our series, we used only the Viabahn
stent graft, and this for three main reasons. First, good
results have been achieved with covered stents in the treat-
ment of occlusive SFA lesions.21,22 Second, the restenosis
rate was low compared with non-covered stents,22,23 and,
finally, there is the possibility of having 10-cm- to 15-cm-
long stents, thus avoiding placement of multiple stents in
the SFA and reducing the fracture rate.
One of the advantages of subintimal angioplasty is the
maintenance of and possible opening up of collaterals,24
which probably explains the high rate of limb salvage with this
technique on the one hand and the possible reocclusion of the
artery without recurrence of symptoms on the other. Some
investigators suggest that stents may jeopardize the collateral
vessels and thus have a detrimental effect onpatency, especially
when stenting concerns the entire length of the recanalized
artery. Treiman et al10 reported a long-term patency rate
that was inferior to that of other studies that did not use
routine stenting and consequently do not recommend
stenting the entire length of the dissection. In our experi-
ence, we found no difference in patency between patients
treated with or without covered stents, so we do not believe
that coverage of the major collateral vessels affects patency.
Schmieder et al9 noted a trend for SA patients receiving
stents to require more open bypass surgery than those
without stents.
The occlusion interval generally reported in the litera-
ture is the first 6 months, except for Treiman et al,10 who
found that patency declined considerably after 24 months.
In our study, as in Yilmaz’s study,25 most thromboses
occurred within the first 6 months with the same kinetics in
both groups. This suggests that a more aggressive surveil-
lance protocol every 3months in the first year is necessary in
order to detect restenosis early and avoid thrombosis, re-
gardless of whether there is a stent or not.
The mortality rate in our series was relatively high
compared with the literature. London et al7 presented a
series of SA on 200 femoro-popliteal artery occlusions with
a 30-day mortality rate of 1.5%. Hynes et al26 reported a
15-year experience of CLI management with SA; the 30-
day mortality rate was 4%. The relatively high mortality rate
in our series can be explained mainly by the fact that all our
patients were ASA grade IV with critical limb ischemia, and
had combined procedures due to extensive lesions. In
retrospect, we now believe that surgical abstention or im-
mediate major amputation should be offered to these pa-
tients.
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retrospective review, which contributed to incomplete data
collection. Second, as the addition of stent is nonrandom-
ized, but depended on the surgeon’s preference and the
extension of the femoro-popliteal occlusion, this might
create bias for the clinical outcome. Our results should thus
be regarded with caution. Third, the relatively small num-
ber of patients in each group and the short follow up do not
permit a further stratification of results. Finally, different
anti-platelet regimens had been used, which creates an-
other bias.
This retrospective clinical study revealed no difference
in the patency of the SA, either with or without stents. We
are, nevertheless, convinced that the results of SA plus
stenting can be improved by treating the origin of the SFA
properly, beyond the proximal occlusion, and by closer
clinical and duplex-scan monitoring, combined with a
more aggressive policy in the treatment of restenosis.
CONCLUSION
Combining subintimal angioplasty and stent grafts of
the entire recanalized artery offers both high technical
success and a satisfactory patency rate. The limb salvage rate
is not affected by the addition of the stent and remains high,
as with the Bolia technique.1
Close monitoring in the first year and the early treat-
ment of restenosis will probably improve the outcome of
the procedure. Our encouraging results allow us to propose
this therapeutic option in the treatment of CLI in elderly
patients, and as a primary therapy with a view to postponing
surgical bypass in patients with intermittent claudication.
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